IRCT20180707040371N1
Completed
Phase 2
Evaluation of blood transfusion intervals in patients with ß-thalassemia major before and after administration of hydroxyurea
Gorgan University of Medical Sciences0 sites20 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Gorgan University of Medical Sciences
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients are ß\-thalassemia major who have been treated with blood transfusion, and after approval of the plan, they are treated monthly with hydroxyurea for 6 months.
Exclusion Criteria
- •Patients who do not tend to take oral medications
- •Patients with unstable hemodynamic status
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
A prospective cohort study of blood transfusion-dependent chronic anemia in AkitaChronic anemia dependent on red cell transfusionJPRN-UMIN000001908Akita University School of Medicine, Department of Medicine, Division of Hematology, Nephrology and Rheumatology100
Not yet recruiting
Not Applicable
To do Hemoglobin of patient before and after giving blood during surgery then decide it was actually neccessary to give blood or notHealth Condition 1: - Health Condition 2: O- Medical and SurgicalCTRI/2024/05/066822Government Medical college and new civil hospital,surat
Completed
Not Applicable
Blood transfusion practices during surgeryCTRI/2017/05/008549Self
Completed
Phase 3
Comparative study on blood transfusion rate and blood loss in postoperative simultaneous bilateral total knee arthroplasty with or without closed suction drainage: Prospective randomized controlled trialBilateral knee osteoarthritis patients receiving simultaneous bilateral TKA surgeryDrain, bilateral total knee arthroplasty, blood transfusion, blood lossTCTR20230116004Chaivat Sriratanavudhi52
Completed
Not Applicable
Transfusion Requirements and Mortality during Extracorporeal Membrane OxygenatioNL-OMON24666/A600